Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 5000.00 | 3570.27 | 5939.00 | 5870.50 | 1.0117 | 1.0326 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 5877.00 | 5870.50 | 1.0011 | 1.0031 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3645.00 | 3914.00 | 0.9313 | 0.8715 | |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5634.00 | 5870.50 | 0.9597 | 0.8886 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5257.00 | 5870.50 | 0.8955 | 0.7148 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 5000.00 | 3570.27 | 2757.00 | 5870.50 | 0.4696 | -0.3025 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 5000.00 | 3570.27 | 4829.00 | 5870.50 | 0.8226 | 0.5234 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1861.36 | 4043.00 | 3914.00 | 1.0330 | 1.0614 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3600.00 | 5870.50 | 0.6132 | 0.0116 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5882.00 | 5870.50 | 1.0020 | 1.0055 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 2500.00 | 1861.36 | 3946.00 | 3914.00 | 1.0082 | 1.0152 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5861.00 | 5870.50 | 0.9984 | 0.9955 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5972.00 | 5870.50 | 1.0173 | 1.0484 | |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 3022.00 | 5870.50 | 0.5148 | -0.2074 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 5000.00 | 3570.27 | 5876.00 | 5870.50 | 1.0009 | 1.0026 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5623.00 | 5870.50 | 0.9578 | 0.8835 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 3570.27 | 5882.00 | 5870.50 | 1.0020 | 1.0055 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5508.00 | 5870.50 | 0.9383 | 0.8300 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6017.00 | 5870.50 | 1.0250 | 1.0699 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 4928.00 | 5870.50 | 0.8395 | 0.5671 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 3917.00 | 5870.50 | 0.6672 | 0.1379 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5483.00 | 5870.50 | 0.9340 | 0.8184 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1679.00 | 3914.00 | 0.4290 | -0.0917 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5359.00 | 5870.50 | 0.9129 | 0.7614 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5954.00 | 5870.50 | 1.0142 | 1.0398 |